id	sid	tid	token	lemma	pos
dpc-1697	1	1	dermatology	dermatology	NOUN
dpc-1697	1	2	:	:	PUNCT
dpc-1697	1	3	practical	practical	ADJ
dpc-1697	1	4	and	and	CCONJ
dpc-1697	1	5	conceptual	conceptual	ADJ
dpc-1697	1	6	research	research	NOUN
dpc-1697	1	7	letter	letter	NOUN
dpc-1697	2	1	|	|	ADV
dpc-1697	2	2	dermatol	dermatol	ADJ
dpc-1697	2	3	pract	pract	NOUN
dpc-1697	2	4	concept	concept	NOUN
dpc-1697	2	5	.	.	PUNCT
dpc-1697	3	1	2022;12(1):e2022019	2022;12(1):e2022019	NUM
dpc-1697	3	2	1research	1research	NUM
dpc-1697	3	3	letter	letter	NOUN
dpc-1697	3	4	|	|	ADV
dpc-1697	3	5	dermatol	dermatol	ADJ
dpc-1697	3	6	pract	pract	NOUN
dpc-1697	3	7	concept	concept	NOUN
dpc-1697	3	8	.	.	PUNCT
dpc-1697	4	1	2022;12(1):e202201	2022;12(1):e202201	NUM
dpc-1697	4	2	1	1	NUM
dpc-1697	4	3	gorlin	gorlin	NOUN
dpc-1697	4	4	syndrome	syndrome	NOUN
dpc-1697	4	5	:	:	PUNCT
dpc-1697	4	6	sequential	sequential	ADJ
dpc-1697	4	7	digital	digital	ADJ
dpc-1697	4	8	dermoscopy	dermoscopy	NOUN
dpc-1697	4	9	of	of	ADP
dpc-1697	4	10	palpebral	palpebral	ADJ
dpc-1697	4	11	basal	basal	NOUN
dpc-1697	4	12	cell	cell	NOUN
dpc-1697	4	13	carcinomas	carcinoma	NOUN
dpc-1697	4	14	in	in	ADP
dpc-1697	4	15	a	a	DET
dpc-1697	4	16	patient	patient	NOUN
dpc-1697	4	17	treated	treat	VERB
dpc-1697	4	18	with	with	ADP
dpc-1697	4	19	vismodegib	vismodegib	PROPN
dpc-1697	4	20	luis	luis	PROPN
dpc-1697	4	21	mena	mena	PROPN
dpc-1697	4	22	-	-	PUNCT
dpc-1697	4	23	vergara1	vergara1	PROPN
dpc-1697	4	24	,	,	PUNCT
dpc-1697	4	25	mariana	mariana	PROPN
dpc-1697	4	26	silva	silva	PROPN
dpc-1697	4	27	-	-	PUNCT
dpc-1697	4	28	astorga1	astorga1	PROPN
dpc-1697	4	29	,	,	PUNCT
dpc-1697	4	30	carolina	carolina	PROPN
dpc-1697	4	31	carrasco	carrasco	PROPN
dpc-1697	4	32	-	-	PUNCT
dpc-1697	4	33	cancino1	cancino1	PROPN
dpc-1697	4	34	,	,	PUNCT
dpc-1697	4	35	leoncio	leoncio	PROPN
dpc-1697	4	36	muñoz	muñoz	PROPN
dpc-1697	4	37	-	-	PUNCT
dpc-1697	4	38	uslar2	uslar2	PROPN
dpc-1697	4	39	1	1	NUM
dpc-1697	4	40	department	department	NOUN
dpc-1697	4	41	of	of	ADP
dpc-1697	4	42	dermatology	dermatology	NOUN
dpc-1697	4	43	,	,	PUNCT
dpc-1697	4	44	faculty	faculty	NOUN
dpc-1697	4	45	of	of	ADP
dpc-1697	4	46	medicine	medicine	NOUN
dpc-1697	4	47	,	,	PUNCT
dpc-1697	4	48	university	university	NOUN
dpc-1697	4	49	of	of	ADP
dpc-1697	4	50	chile	chile	PROPN
dpc-1697	4	51	,	,	PUNCT
dpc-1697	4	52	santiago	santiago	PROPN
dpc-1697	4	53	,	,	PUNCT
dpc-1697	4	54	chile	chile	NOUN
dpc-1697	4	55	2	2	NUM
dpc-1697	4	56	dermatology	dermatology	NOUN
dpc-1697	4	57	service	service	NOUN
dpc-1697	4	58	,	,	PUNCT
dpc-1697	4	59	hospital	hospital	NOUN
dpc-1697	4	60	del	del	PROPN
dpc-1697	4	61	salvador	salvador	PROPN
dpc-1697	4	62	,	,	PUNCT
dpc-1697	4	63	santiago	santiago	PROPN
dpc-1697	4	64	,	,	PUNCT
dpc-1697	4	65	chile	chile	VERB
dpc-1697	4	66	key	key	ADJ
dpc-1697	4	67	words	word	NOUN
dpc-1697	4	68	:	:	PUNCT
dpc-1697	4	69	gorlin	gorlin	PROPN
dpc-1697	4	70	syndrome	syndrome	PROPN
dpc-1697	4	71	,	,	PUNCT
dpc-1697	4	72	digital	digital	ADJ
dpc-1697	4	73	dermoscopy	dermoscopy	NOUN
dpc-1697	4	74	,	,	PUNCT
dpc-1697	4	75	palpebral	palpebral	ADJ
dpc-1697	4	76	basal	basal	NOUN
dpc-1697	4	77	cell	cell	NOUN
dpc-1697	4	78	carcinoma	carcinoma	NOUN
dpc-1697	4	79	,	,	PUNCT
dpc-1697	4	80	vismodegib	vismodegib	PROPN
dpc-1697	4	81	citation	citation	NOUN
dpc-1697	4	82	:	:	PUNCT
dpc-1697	4	83	mena	mena	PROPN
dpc-1697	4	84	-	-	PUNCT
dpc-1697	4	85	vergara	vergara	PROPN
dpc-1697	4	86	l	l	PROPN
dpc-1697	4	87	,	,	PUNCT
dpc-1697	4	88	silva	silva	NOUN
dpc-1697	4	89	-	-	PUNCT
dpc-1697	4	90	astorga	astorga	PROPN
dpc-1697	4	91	m	m	PROPN
dpc-1697	4	92	,	,	PUNCT
dpc-1697	4	93	carrasco	carrasco	PROPN
dpc-1697	4	94	-	-	PUNCT
dpc-1697	4	95	cancino	cancino	PROPN
dpc-1697	4	96	c	c	PROPN
dpc-1697	4	97	,	,	PUNCT
dpc-1697	4	98	muñoz	muñoz	PROPN
dpc-1697	4	99	-	-	PUNCT
dpc-1697	4	100	uslar	uslar	ADJ
dpc-1697	4	101	l.	l.	PROPN
dpc-1697	4	102	gorlin	gorlin	PROPN
dpc-1697	4	103	syndrome	syndrome	PROPN
dpc-1697	4	104	:	:	PUNCT
dpc-1697	4	105	sequential	sequential	ADJ
dpc-1697	4	106	digital	digital	ADJ
dpc-1697	4	107	dermoscopy	dermoscopy	NOUN
dpc-1697	4	108	of	of	ADP
dpc-1697	4	109	palpebral	palpebral	ADJ
dpc-1697	4	110	basal	basal	NOUN
dpc-1697	4	111	cell	cell	NOUN
dpc-1697	4	112	carcinomas	carcinoma	NOUN
dpc-1697	4	113	in	in	ADP
dpc-1697	4	114	a	a	DET
dpc-1697	4	115	patient	patient	NOUN
dpc-1697	4	116	treated	treat	VERB
dpc-1697	4	117	with	with	ADP
dpc-1697	4	118	vismodegib	vismodegib	NOUN
dpc-1697	4	119	.	.	PUNCT
dpc-1697	5	1	dermatol	dermatol	NOUN
dpc-1697	5	2	pract	pract	PROPN
dpc-1697	5	3	concept	concept	NOUN
dpc-1697	5	4	.	.	PUNCT
dpc-1697	6	1	2022;12(1):e2022019	2022;12(1):e2022019	NUM
dpc-1697	6	2	.	.	PUNCT
dpc-1697	7	1	doi	doi	NOUN
dpc-1697	7	2	:	:	PUNCT
dpc-1697	7	3	https://doi.org/10.5826/dpc.1201a19	https://doi.org/10.5826/dpc.1201a19	PROPN
dpc-1697	7	4	accepted	accept	VERB
dpc-1697	7	5	:	:	PUNCT
dpc-1697	7	6	may	may	AUX
dpc-1697	7	7	26	26	NUM
dpc-1697	7	8	,	,	PUNCT
dpc-1697	7	9	2021	2021	NUM
dpc-1697	7	10	;	;	PUNCT
dpc-1697	7	11	published	publish	VERB
dpc-1697	7	12	:	:	PUNCT
dpc-1697	7	13	january	january	PROPN
dpc-1697	7	14	2022	2022	NUM
dpc-1697	8	1	copyright	copyright	NOUN
dpc-1697	8	2	:	:	PUNCT
dpc-1697	8	3	©	©	PROPN
dpc-1697	8	4	2022	2022	NUM
dpc-1697	8	5	mena	mena	PROPN
dpc-1697	8	6	-	-	PUNCT
dpc-1697	8	7	vergara	vergara	PROPN
dpc-1697	8	8	et	et	PROPN
dpc-1697	8	9	al	al	PROPN
dpc-1697	8	10	.	.	PUNCT
dpc-1697	9	1	this	this	PRON
dpc-1697	9	2	is	be	AUX
dpc-1697	9	3	an	an	DET
dpc-1697	9	4	open	open	ADJ
dpc-1697	9	5	-	-	PUNCT
dpc-1697	9	6	access	access	NOUN
dpc-1697	9	7	article	article	NOUN
dpc-1697	9	8	distributed	distribute	VERB
dpc-1697	9	9	under	under	ADP
dpc-1697	9	10	the	the	DET
dpc-1697	9	11	terms	term	NOUN
dpc-1697	9	12	of	of	ADP
dpc-1697	9	13	the	the	DET
dpc-1697	9	14	creative	creative	ADJ
dpc-1697	9	15	commons	common	NOUN
dpc-1697	9	16	attributionnoncommercial	attributionnoncommercial	ADJ
dpc-1697	9	17	license	license	NOUN
dpc-1697	9	18	(	(	PUNCT
dpc-1697	9	19	by	by	ADP
dpc-1697	9	20	-	-	PUNCT
dpc-1697	9	21	nc-4.0	nc-4.0	NOUN
dpc-1697	9	22	)	)	PUNCT
dpc-1697	9	23	,	,	PUNCT
dpc-1697	9	24	https://creativecommons.org/licenses/by-nc/4.0/	https://creativecommons.org/licenses/by-nc/4.0/	PROPN
dpc-1697	9	25	,	,	PUNCT
dpc-1697	9	26	which	which	PRON
dpc-1697	9	27	permits	permit	VERB
dpc-1697	9	28	unrestricted	unrestricted	ADJ
dpc-1697	9	29	noncommercial	noncommercial	ADJ
dpc-1697	9	30	use	use	NOUN
dpc-1697	9	31	,	,	PUNCT
dpc-1697	9	32	distribution	distribution	NOUN
dpc-1697	9	33	,	,	PUNCT
dpc-1697	9	34	and	and	CCONJ
dpc-1697	9	35	reproduction	reproduction	NOUN
dpc-1697	9	36	in	in	ADP
dpc-1697	9	37	any	any	DET
dpc-1697	9	38	medium	medium	NOUN
dpc-1697	9	39	,	,	PUNCT
dpc-1697	9	40	provided	provide	VERB
dpc-1697	9	41	the	the	DET
dpc-1697	9	42	original	original	ADJ
dpc-1697	9	43	authors	author	NOUN
dpc-1697	9	44	and	and	CCONJ
dpc-1697	9	45	source	source	NOUN
dpc-1697	9	46	are	be	AUX
dpc-1697	9	47	credited	credit	VERB
dpc-1697	9	48	.	.	PUNCT
dpc-1697	10	1	funding	funding	NOUN
dpc-1697	10	2	:	:	PUNCT
dpc-1697	10	3	none	none	NOUN
dpc-1697	10	4	.	.	PUNCT
dpc-1697	11	1	competing	compete	VERB
dpc-1697	11	2	interests	interest	NOUN
dpc-1697	11	3	:	:	PUNCT
dpc-1697	11	4	none	none	NOUN
dpc-1697	11	5	.	.	PUNCT
dpc-1697	12	1	authorship	authorship	NOUN
dpc-1697	12	2	:	:	PUNCT
dpc-1697	12	3	all	all	DET
dpc-1697	12	4	authors	author	NOUN
dpc-1697	12	5	have	have	AUX
dpc-1697	12	6	contributed	contribute	VERB
dpc-1697	12	7	significantly	significantly	ADV
dpc-1697	12	8	to	to	ADP
dpc-1697	12	9	this	this	DET
dpc-1697	12	10	publication	publication	NOUN
dpc-1697	12	11	.	.	PUNCT
dpc-1697	13	1	corresponding	correspond	VERB
dpc-1697	13	2	author	author	NOUN
dpc-1697	13	3	:	:	PUNCT
dpc-1697	13	4	mariana	mariana	PROPN
dpc-1697	13	5	silva	silva	PROPN
dpc-1697	13	6	astorga	astorga	PROPN
dpc-1697	13	7	,	,	PUNCT
dpc-1697	13	8	department	department	NOUN
dpc-1697	13	9	of	of	ADP
dpc-1697	13	10	dermatology	dermatology	NOUN
dpc-1697	13	11	,	,	PUNCT
dpc-1697	13	12	university	university	NOUN
dpc-1697	13	13	of	of	ADP
dpc-1697	13	14	chile	chile	PROPN
dpc-1697	13	15	,	,	PUNCT
dpc-1697	13	16	santiago	santiago	PROPN
dpc-1697	13	17	,	,	PUNCT
dpc-1697	13	18	chile	chile	PROPN
dpc-1697	13	19	.	.	PUNCT
dpc-1697	14	1	e	e	X
dpc-1697	14	2	-	-	NOUN
dpc-1697	14	3	mail	mail	NOUN
dpc-1697	14	4	:	:	PUNCT
dpc-1697	14	5	valesilva.astorga@gmail.com	valesilva.astorga@gmail.com	X
dpc-1697	14	6	introduction	introduction	NOUN
dpc-1697	14	7	gorlin	gorlin	NOUN
dpc-1697	14	8	-	-	PUNCT
dpc-1697	14	9	goltz	goltz	NOUN
dpc-1697	14	10	syndrome	syndrome	NOUN
dpc-1697	14	11	(	(	PUNCT
dpc-1697	14	12	gs	gs	NOUN
dpc-1697	14	13	)	)	PUNCT
dpc-1697	14	14	 	 	SPACE
dpc-1697	14	15	is	be	AUX
dpc-1697	14	16	a	a	DET
dpc-1697	14	17	multi	multi	ADJ
dpc-1697	14	18	-	-	ADJ
dpc-1697	14	19	system	system	ADJ
dpc-1697	14	20	genetic	genetic	ADJ
dpc-1697	14	21	disorder	disorder	NOUN
dpc-1697	14	22	,	,	PUNCT
dpc-1697	14	23	characterized	characterize	VERB
dpc-1697	14	24	by	by	ADP
dpc-1697	14	25	the	the	DET
dpc-1697	14	26	development	development	NOUN
dpc-1697	14	27	of	of	ADP
dpc-1697	14	28	jaw	jaw	PROPN
dpc-1697	14	29	keratocystic	keratocystic	ADJ
dpc-1697	14	30	odontogenic	odontogenic	ADJ
dpc-1697	14	31	tumors	tumor	NOUN
dpc-1697	14	32	(	(	PUNCT
dpc-1697	14	33	kot	kot	PROPN
dpc-1697	14	34	)	)	PUNCT
dpc-1697	14	35	and	and	CCONJ
dpc-1697	14	36	multiple	multiple	ADJ
dpc-1697	14	37	basal	basal	NOUN
dpc-1697	14	38	cell	cell	NOUN
dpc-1697	14	39	carcinoma	carcinoma	NOUN
dpc-1697	14	40	(	(	PUNCT
dpc-1697	14	41	bcc	bcc	PROPN
dpc-1697	14	42	)	)	PUNCT
dpc-1697	14	43	at	at	ADP
dpc-1697	14	44	young	young	ADJ
dpc-1697	14	45	ages	age	NOUN
dpc-1697	14	46	.	.	PUNCT
dpc-1697	15	1	patients	patient	NOUN
dpc-1697	15	2	inherit	inherit	VERB
dpc-1697	15	3	a	a	DET
dpc-1697	15	4	defective	defective	ADJ
dpc-1697	15	5	copy	copy	NOUN
dpc-1697	15	6	of	of	ADP
dpc-1697	15	7	ptch1	ptch1	PROPN
dpc-1697	15	8	,	,	PUNCT
dpc-1697	15	9	a	a	DET
dpc-1697	15	10	tumor	tumor	NOUN
dpc-1697	15	11	suppressor	suppressor	NOUN
dpc-1697	15	12	gene	gene	NOUN
dpc-1697	15	13	,	,	PUNCT
dpc-1697	15	14	responsible	responsible	ADJ
dpc-1697	15	15	for	for	ADP
dpc-1697	15	16	hedgehog	hedgehog	NOUN
dpc-1697	15	17	pathway	pathway	NOUN
dpc-1697	15	18	signaling	signal	VERB
dpc-1697	15	19	(	(	PUNCT
dpc-1697	15	20	hps	hps	NOUN
dpc-1697	15	21	)	)	PUNCT
dpc-1697	15	22	inhibition	inhibition	NOUN
dpc-1697	15	23	.	.	PUNCT
dpc-1697	15	24	 	 	SPACE
dpc-1697	16	1	ptch1	ptch1	NOUN
dpc-1697	16	2	mutations	mutation	NOUN
dpc-1697	16	3	and	and	CCONJ
dpc-1697	16	4	loss	loss	NOUN
dpc-1697	16	5	of	of	ADP
dpc-1697	16	6	the	the	DET
dpc-1697	16	7	remaining	remain	VERB
dpc-1697	16	8	wild	wild	ADJ
dpc-1697	16	9	-	-	PUNCT
dpc-1697	16	10	type	type	NOUN
dpc-1697	16	11	allele	allele	NOUN
dpc-1697	16	12	are	be	AUX
dpc-1697	16	13	also	also	ADV
dpc-1697	16	14	exhibited	exhibit	VERB
dpc-1697	16	15	in	in	ADP
dpc-1697	16	16	>	>	ADP
dpc-1697	16	17	90	90	NUM
dpc-1697	16	18	%	%	NOUN
dpc-1697	16	19	of	of	ADP
dpc-1697	16	20	sporadic	sporadic	ADJ
dpc-1697	16	21	bccs	bccs	NOUN
dpc-1697	17	1	[	[	X
dpc-1697	17	2	1	1	NUM
dpc-1697	17	3	]	]	PUNCT
dpc-1697	17	4	.	.	PUNCT
dpc-1697	17	5	 	 	SPACE
dpc-1697	18	1	while	while	SCONJ
dpc-1697	18	2	most	most	ADJ
dpc-1697	18	3	cases	case	NOUN
dpc-1697	18	4	are	be	AUX
dpc-1697	18	5	amenable	amenable	ADJ
dpc-1697	18	6	to	to	ADP
dpc-1697	18	7	surgery	surgery	NOUN
dpc-1697	18	8	,	,	PUNCT
dpc-1697	18	9	locally	locally	ADV
dpc-1697	18	10	advanced	advanced	ADJ
dpc-1697	18	11	bccs	bccs	NOUN
dpc-1697	18	12	and	and	CCONJ
dpc-1697	18	13	unresectable	unresectable	ADJ
dpc-1697	18	14	tumors	tumor	NOUN
dpc-1697	18	15	represent	represent	VERB
dpc-1697	18	16	a	a	DET
dpc-1697	18	17	complex	complex	ADJ
dpc-1697	18	18	scenario	scenario	NOUN
dpc-1697	18	19	,	,	PUNCT
dpc-1697	18	20	in	in	ADP
dpc-1697	18	21	which	which	PRON
dpc-1697	18	22	hps	hps	NOUN
dpc-1697	18	23	inhibitors	inhibitor	NOUN
dpc-1697	18	24	may	may	AUX
dpc-1697	18	25	be	be	AUX
dpc-1697	18	26	a	a	DET
dpc-1697	18	27	feasible	feasible	ADJ
dpc-1697	18	28	treatment	treatment	NOUN
dpc-1697	18	29	option	option	NOUN
dpc-1697	18	30	with	with	ADP
dpc-1697	18	31	better	well	ADJ
dpc-1697	18	32	clinical	clinical	ADJ
dpc-1697	18	33	outcomes	outcome	NOUN
dpc-1697	18	34	[	[	X
dpc-1697	18	35	1	1	NUM
dpc-1697	18	36	]	]	PUNCT
dpc-1697	18	37	.	.	PUNCT
dpc-1697	19	1	digital	digital	ADJ
dpc-1697	19	2	images	image	NOUN
dpc-1697	19	3	can	can	AUX
dpc-1697	19	4	be	be	AUX
dpc-1697	19	5	useful	useful	ADJ
dpc-1697	19	6	in	in	ADP
dpc-1697	19	7	following	follow	VERB
dpc-1697	19	8	up	up	ADP
dpc-1697	19	9	bcc	bcc	PROPN
dpc-1697	19	10	response	response	NOUN
dpc-1697	19	11	to	to	ADP
dpc-1697	19	12	treatment	treatment	NOUN
dpc-1697	19	13	[	[	X
dpc-1697	19	14	2	2	NUM
dpc-1697	19	15	]	]	PUNCT
dpc-1697	19	16	.	.	PUNCT
dpc-1697	20	1	we	we	PRON
dpc-1697	20	2	describe	describe	VERB
dpc-1697	20	3	the	the	DET
dpc-1697	20	4	involution	involution	NOUN
dpc-1697	20	5	of	of	ADP
dpc-1697	20	6	bccs	bccs	PROPN
dpc-1697	20	7	dermoscopic	dermoscopic	PROPN
dpc-1697	20	8	criteria	criterion	NOUN
dpc-1697	20	9	recorded	record	VERB
dpc-1697	20	10	with	with	ADP
dpc-1697	20	11	sequential	sequential	ADJ
dpc-1697	20	12	digital	digital	ADJ
dpc-1697	20	13	dermoscopy	dermoscopy	NOUN
dpc-1697	20	14	(	(	PUNCT
dpc-1697	20	15	sdd	sdd	NOUN
dpc-1697	20	16	)	)	PUNCT
dpc-1697	20	17	,	,	PUNCT
dpc-1697	20	18	in	in	ADP
dpc-1697	20	19	a	a	DET
dpc-1697	20	20	patient	patient	NOUN
dpc-1697	20	21	with	with	ADP
dpc-1697	20	22	gs	gs	NOUN
dpc-1697	20	23	during	during	ADP
dpc-1697	20	24	treatment	treatment	NOUN
dpc-1697	20	25	with	with	ADP
dpc-1697	20	26	vismodegib	vismodegib	NOUN
dpc-1697	20	27	.	.	PUNCT
dpc-1697	21	1	case	case	NOUN
dpc-1697	21	2	presentation	presentation	NOUN
dpc-1697	21	3	a	a	DET
dpc-1697	21	4	58	58	NUM
dpc-1697	21	5	-	-	PUNCT
dpc-1697	21	6	year	year	NOUN
dpc-1697	21	7	-	-	PUNCT
dpc-1697	21	8	old	old	ADJ
dpc-1697	21	9	man	man	NOUN
dpc-1697	21	10	with	with	ADP
dpc-1697	21	11	gs	gs	PROPN
dpc-1697	21	12	diagnosed	diagnose	VERB
dpc-1697	21	13	at	at	ADP
dpc-1697	21	14	age	age	NOUN
dpc-1697	21	15	of	of	ADP
dpc-1697	21	16	7	7	NUM
dpc-1697	21	17	years	year	NOUN
dpc-1697	21	18	,	,	PUNCT
dpc-1697	21	19	presented	present	VERB
dpc-1697	21	20	with	with	ADP
dpc-1697	21	21	over	over	ADP
dpc-1697	21	22	50	50	NUM
dpc-1697	21	23	tumoral	tumoral	ADJ
dpc-1697	21	24	lesions	lesion	NOUN
dpc-1697	21	25	and	and	CCONJ
dpc-1697	21	26	the	the	DET
dpc-1697	21	27	presence	presence	NOUN
dpc-1697	21	28	of	of	ADP
dpc-1697	21	29	multiple	multiple	ADJ
dpc-1697	21	30	bccs	bccs	NOUN
dpc-1697	21	31	in	in	ADP
dpc-1697	21	32	both	both	DET
dpc-1697	21	33	eyelids	eyelid	NOUN
dpc-1697	21	34	was	be	AUX
dpc-1697	21	35	noted	note	VERB
dpc-1697	21	36	(	(	PUNCT
dpc-1697	21	37	figure	figure	NOUN
dpc-1697	21	38	1a	1a	NOUN
dpc-1697	21	39	)	)	PUNCT
dpc-1697	21	40	.	.	PUNCT
dpc-1697	22	1	he	he	PRON
dpc-1697	22	2	had	have	VERB
dpc-1697	22	3	history	history	NOUN
dpc-1697	22	4	of	of	ADP
dpc-1697	22	5	several	several	ADJ
dpc-1697	22	6	surgical	surgical	ADJ
dpc-1697	22	7	interventions	intervention	NOUN
dpc-1697	22	8	to	to	PART
dpc-1697	22	9	remove	remove	VERB
dpc-1697	22	10	kots	kot	NOUN
dpc-1697	22	11	and	and	CCONJ
dpc-1697	22	12	bccs	bcc	VERB
dpc-1697	22	13	with	with	ADP
dpc-1697	22	14	torpid	torpid	ADJ
dpc-1697	22	15	evolution	evolution	NOUN
dpc-1697	22	16	and	and	CCONJ
dpc-1697	22	17	development	development	NOUN
dpc-1697	22	18	of	of	ADP
dpc-1697	22	19	retractile	retractile	NOUN
dpc-1697	22	20	scars	scar	NOUN
dpc-1697	22	21	that	that	PRON
dpc-1697	22	22	in	in	ADP
dpc-1697	22	23	turn	turn	NOUN
dpc-1697	22	24	required	require	VERB
dpc-1697	22	25	advanced	advanced	ADJ
dpc-1697	22	26	plastic	plastic	ADJ
dpc-1697	22	27	surgical	surgical	ADJ
dpc-1697	22	28	treatment	treatment	NOUN
dpc-1697	22	29	to	to	PART
dpc-1697	22	30	maintain	maintain	VERB
dpc-1697	22	31	functionality	functionality	NOUN
dpc-1697	22	32	,	,	PUNCT
dpc-1697	22	33	resulting	result	VERB
dpc-1697	22	34	in	in	ADP
dpc-1697	22	35	aesthetic	aesthetic	ADJ
dpc-1697	22	36	alterations	alteration	NOUN
dpc-1697	22	37	(	(	PUNCT
dpc-1697	22	38	figure	figure	NOUN
dpc-1697	22	39	1a	1a	NOUN
dpc-1697	22	40	)	)	PUNCT
dpc-1697	22	41	.	.	PUNCT
dpc-1697	23	1	due	due	ADP
dpc-1697	23	2	to	to	ADP
dpc-1697	23	3	the	the	DET
dpc-1697	23	4	high	high	ADJ
dpc-1697	23	5	risk	risk	NOUN
dpc-1697	23	6	of	of	ADP
dpc-1697	23	7	causing	cause	VERB
dpc-1697	23	8	severe	severe	ADJ
dpc-1697	23	9	ocular	ocular	ADJ
dpc-1697	23	10	morbidity	morbidity	NOUN
dpc-1697	23	11	with	with	ADP
dpc-1697	23	12	a	a	DET
dpc-1697	23	13	new	new	ADJ
dpc-1697	23	14	surgery	surgery	NOUN
dpc-1697	23	15	,	,	PUNCT
dpc-1697	23	16	vismodegib	vismodegib	NOUN
dpc-1697	23	17	was	be	AUX
dpc-1697	23	18	initiated	initiate	VERB
dpc-1697	23	19	,	,	PUNCT
dpc-1697	23	20	resulting	result	VERB
dpc-1697	23	21	in	in	ADP
dpc-1697	23	22	a	a	DET
dpc-1697	23	23	significant	significant	ADJ
dpc-1697	23	24	clinical	clinical	ADJ
dpc-1697	23	25	response	response	NOUN
dpc-1697	23	26	after	after	ADP
dpc-1697	23	27	2	2	NUM
dpc-1697	23	28	months	month	NOUN
dpc-1697	23	29	.	.	PUNCT
dpc-1697	24	1	ssd	ssd	PROPN
dpc-1697	24	2	was	be	AUX
dpc-1697	24	3	performed	perform	VERB
dpc-1697	24	4	before	before	ADP
dpc-1697	24	5	and	and	CCONJ
dpc-1697	24	6	during	during	ADP
dpc-1697	24	7	treatment	treatment	NOUN
dpc-1697	24	8	,	,	PUNCT
dpc-1697	24	9	and	and	CCONJ
dpc-1697	24	10	it	it	PRON
dpc-1697	24	11	revealed	reveal	VERB
dpc-1697	24	12	shrinking	shrinking	NOUN
dpc-1697	24	13	of	of	ADP
dpc-1697	24	14	palpebral	palpebral	ADJ
dpc-1697	24	15	tumors	tumor	NOUN
dpc-1697	24	16	and	and	CCONJ
dpc-1697	24	17	regression	regression	NOUN
dpc-1697	24	18	of	of	ADP
dpc-1697	24	19	dermoscopic	dermoscopic	ADJ
dpc-1697	24	20	structures	structure	NOUN
dpc-1697	24	21	(	(	PUNCT
dpc-1697	24	22	figures	figure	NOUN
dpc-1697	24	23	1	1	NUM
dpc-1697	24	24	and	and	CCONJ
dpc-1697	24	25	2	2	NUM
dpc-1697	24	26	)	)	PUNCT
dpc-1697	24	27	.	.	PUNCT
dpc-1697	25	1	2	2	NUM
dpc-1697	25	2	research	research	NOUN
dpc-1697	25	3	letter	letter	NOUN
dpc-1697	25	4	|	|	ADV
dpc-1697	25	5	dermatol	dermatol	ADJ
dpc-1697	25	6	pract	pract	NOUN
dpc-1697	25	7	concept	concept	NOUN
dpc-1697	25	8	.	.	PUNCT
dpc-1697	26	1	2022;12(1):e2022019	2022;12(1):e2022019	NUM
dpc-1697	26	2	figure	figure	NOUN
dpc-1697	26	3	1	1	NUM
dpc-1697	26	4	.	.	PUNCT
dpc-1697	27	1	(	(	PUNCT
dpc-1697	27	2	a	a	X
dpc-1697	27	3	)	)	PUNCT
dpc-1697	27	4	retractile	retractile	NOUN
dpc-1697	27	5	scars	scar	NOUN
dpc-1697	27	6	due	due	ADJ
dpc-1697	27	7	to	to	ADP
dpc-1697	27	8	several	several	ADJ
dpc-1697	27	9	surgical	surgical	ADJ
dpc-1697	27	10	interventions	intervention	NOUN
dpc-1697	27	11	with	with	ADP
dpc-1697	27	12	secondary	secondary	ADJ
dpc-1697	27	13	bilateral	bilateral	ADJ
dpc-1697	27	14	ectropion	ectropion	NOUN
dpc-1697	27	15	and	and	CCONJ
dpc-1697	27	16	ptosis	ptosis	NOUN
dpc-1697	27	17	.	.	PUNCT
dpc-1697	28	1	multiple	multiple	ADJ
dpc-1697	28	2	bccs	bccs	NOUN
dpc-1697	28	3	involving	involve	VERB
dpc-1697	28	4	the	the	DET
dpc-1697	28	5	scalp	scalp	NOUN
dpc-1697	28	6	and	and	CCONJ
dpc-1697	28	7	periocular	periocular	ADJ
dpc-1697	28	8	area	area	NOUN
dpc-1697	28	9	(	(	PUNCT
dpc-1697	28	10	white	white	ADJ
dpc-1697	28	11	arrows	arrow	NOUN
dpc-1697	28	12	)	)	PUNCT
dpc-1697	28	13	.	.	PUNCT
dpc-1697	29	1	(	(	PUNCT
dpc-1697	29	2	b	b	X
dpc-1697	29	3	)	)	PUNCT
dpc-1697	29	4	pigmented	pigment	VERB
dpc-1697	29	5	bcc	bcc	PROPN
dpc-1697	29	6	in	in	ADP
dpc-1697	29	7	superior	superior	ADJ
dpc-1697	29	8	left	left	ADJ
dpc-1697	29	9	eyelid	eyelid	NOUN
dpc-1697	29	10	before	before	ADP
dpc-1697	29	11	vismodegib	vismodegib	NOUN
dpc-1697	29	12	:	:	PUNCT
dpc-1697	29	13	typical	typical	ADJ
dpc-1697	29	14	dermoscopic	dermoscopic	ADJ
dpc-1697	29	15	structures	structure	NOUN
dpc-1697	29	16	,	,	PUNCT
dpc-1697	29	17	blue	blue	ADJ
dpc-1697	29	18	-	-	PUNCT
dpc-1697	29	19	gray	gray	ADJ
dpc-1697	29	20	globules	globule	NOUN
dpc-1697	29	21	,	,	PUNCT
dpc-1697	29	22	ovoid	ovoid	ADJ
dpc-1697	29	23	nest	nest	NOUN
dpc-1697	29	24	and	and	CCONJ
dpc-1697	29	25	arborizing	arborize	VERB
dpc-1697	29	26	vessels	vessel	NOUN
dpc-1697	29	27	(	(	PUNCT
dpc-1697	29	28	blue	blue	ADJ
dpc-1697	29	29	arrow	arrow	NOUN
dpc-1697	29	30	)	)	PUNCT
dpc-1697	29	31	.	.	PUNCT
dpc-1697	30	1	(	(	PUNCT
dpc-1697	30	2	c	c	X
dpc-1697	30	3	)	)	PUNCT
dpc-1697	30	4	week	week	NOUN
dpc-1697	30	5	2	2	NUM
dpc-1697	30	6	:	:	PUNCT
dpc-1697	30	7	disappearance	disappearance	NOUN
dpc-1697	30	8	of	of	ADP
dpc-1697	30	9	some	some	DET
dpc-1697	30	10	globules	globule	NOUN
dpc-1697	30	11	(	(	PUNCT
dpc-1697	30	12	white	white	PROPN
dpc-1697	30	13	circle	circle	PROPN
dpc-1697	30	14	)	)	PUNCT
dpc-1697	30	15	and	and	CCONJ
dpc-1697	30	16	less	less	ADV
dpc-1697	30	17	notorious	notorious	ADJ
dpc-1697	30	18	telangiectasia	telangiectasia	NOUN
dpc-1697	30	19	(	(	PUNCT
dpc-1697	30	20	blue	blue	ADJ
dpc-1697	30	21	arrows	arrow	NOUN
dpc-1697	30	22	)	)	PUNCT
dpc-1697	30	23	.	.	PUNCT
dpc-1697	31	1	(	(	PUNCT
dpc-1697	31	2	d	d	X
dpc-1697	31	3	)	)	PUNCT
dpc-1697	31	4	week	week	NOUN
dpc-1697	31	5	7	7	NUM
dpc-1697	31	6	:	:	PUNCT
dpc-1697	31	7	arborizing	arborize	VERB
dpc-1697	31	8	vessels	vessel	NOUN
dpc-1697	31	9	are	be	AUX
dpc-1697	31	10	no	no	ADV
dpc-1697	31	11	longer	long	ADV
dpc-1697	31	12	visible	visible	ADJ
dpc-1697	31	13	(	(	PUNCT
dpc-1697	31	14	blue	blue	ADJ
dpc-1697	31	15	circle	circle	NOUN
dpc-1697	31	16	)	)	PUNCT
dpc-1697	31	17	.	.	PUNCT
dpc-1697	32	1	(	(	PUNCT
dpc-1697	32	2	e	e	NOUN
dpc-1697	32	3	)	)	PUNCT
dpc-1697	32	4	week	week	NOUN
dpc-1697	32	5	8	8	NUM
dpc-1697	32	6	:	:	PUNCT
dpc-1697	32	7	notable	notable	ADJ
dpc-1697	32	8	regression	regression	NOUN
dpc-1697	32	9	of	of	ADP
dpc-1697	32	10	bcc	bcc	PROPN
dpc-1697	32	11	structures	structure	NOUN
dpc-1697	32	12	;	;	PUNCT
dpc-1697	32	13	only	only	ADV
dpc-1697	32	14	a	a	DET
dpc-1697	32	15	few	few	ADJ
dpc-1697	32	16	blue	blue	ADJ
dpc-1697	32	17	-	-	PUNCT
dpc-1697	32	18	gray	gray	ADJ
dpc-1697	32	19	globules	globule	NOUN
dpc-1697	32	20	persist	persist	NOUN
dpc-1697	32	21	.	.	PUNCT
dpc-1697	33	1	figure	figure	NOUN
dpc-1697	33	2	2	2	NUM
dpc-1697	33	3	.	.	PUNCT
dpc-1697	33	4	nonpigmented	nonpigmente	VERB
dpc-1697	33	5	basal	basal	PROPN
dpc-1697	33	6	cell	cell	NOUN
dpc-1697	33	7	carcinoma	carcinoma	NOUN
dpc-1697	33	8	(	(	PUNCT
dpc-1697	33	9	bcc	bcc	PROPN
dpc-1697	33	10	)	)	PUNCT
dpc-1697	33	11	in	in	ADP
dpc-1697	33	12	superior	superior	ADJ
dpc-1697	33	13	left	left	ADJ
dpc-1697	33	14	eyelid	eyelid	NOUN
dpc-1697	33	15	.	.	PUNCT
dpc-1697	34	1	(	(	PUNCT
dpc-1697	34	2	a	a	X
dpc-1697	34	3	)	)	PUNCT
dpc-1697	34	4	before	before	ADP
dpc-1697	34	5	vismodegib	vismodegib	NOUN
dpc-1697	34	6	.	.	PUNCT
dpc-1697	35	1	dermoscopic	dermoscopic	NOUN
dpc-1697	35	2	structures	structure	NOUN
dpc-1697	35	3	of	of	ADP
dpc-1697	35	4	a	a	DET
dpc-1697	35	5	nonpigmented	nonpigmented	ADJ
dpc-1697	35	6	bcc	bcc	PROPN
dpc-1697	35	7	:	:	PUNCT
dpc-1697	35	8	multiple	multiple	ADJ
dpc-1697	35	9	fine	fine	ADJ
dpc-1697	35	10	telangiectasia	telangiectasia	NOUN
dpc-1697	35	11	(	(	PUNCT
dpc-1697	35	12	red	red	ADJ
dpc-1697	35	13	circle	circle	PROPN
dpc-1697	35	14	)	)	PUNCT
dpc-1697	35	15	,	,	PUNCT
dpc-1697	35	16	crusting	crust	VERB
dpc-1697	35	17	(	(	PUNCT
dpc-1697	35	18	blue	blue	ADJ
dpc-1697	35	19	arrows	arrow	NOUN
dpc-1697	35	20	)	)	PUNCT
dpc-1697	35	21	,	,	PUNCT
dpc-1697	35	22	whitish	whitish	ADJ
dpc-1697	35	23	unstructured	unstructured	ADJ
dpc-1697	35	24	zones	zone	NOUN
dpc-1697	35	25	(	(	PUNCT
dpc-1697	35	26	green	green	ADJ
dpc-1697	35	27	arrows	arrow	NOUN
dpc-1697	35	28	)	)	PUNCT
dpc-1697	35	29	.	.	PUNCT
dpc-1697	36	1	(	(	PUNCT
dpc-1697	36	2	b	b	X
dpc-1697	36	3	)	)	PUNCT
dpc-1697	36	4	week	week	NOUN
dpc-1697	36	5	2	2	NUM
dpc-1697	36	6	:	:	PUNCT
dpc-1697	36	7	notable	notable	ADJ
dpc-1697	36	8	less	less	ADV
dpc-1697	36	9	crusting	crusting	NOUN
dpc-1697	36	10	and	and	CCONJ
dpc-1697	36	11	shrinking	shrinking	NOUN
dpc-1697	36	12	of	of	ADP
dpc-1697	36	13	whitish	whitish	ADJ
dpc-1697	36	14	unstructured	unstructured	ADJ
dpc-1697	36	15	areas	area	NOUN
dpc-1697	36	16	(	(	PUNCT
dpc-1697	36	17	green	green	ADJ
dpc-1697	36	18	stars	star	NOUN
dpc-1697	36	19	)	)	PUNCT
dpc-1697	36	20	.	.	PUNCT
dpc-1697	37	1	(	(	PUNCT
dpc-1697	37	2	c	c	X
dpc-1697	37	3	)	)	PUNCT
dpc-1697	37	4	week	week	NOUN
dpc-1697	37	5	7	7	NUM
dpc-1697	37	6	:	:	PUNCT
dpc-1697	37	7	a	a	DET
dpc-1697	37	8	few	few	ADJ
dpc-1697	37	9	fine	fine	ADJ
dpc-1697	37	10	telangiectasias	telangiectasia	NOUN
dpc-1697	37	11	persist	persist	VERB
dpc-1697	37	12	,	,	PUNCT
dpc-1697	37	13	whitish	whitish	ADJ
dpc-1697	37	14	areas	area	NOUN
dpc-1697	37	15	are	be	AUX
dpc-1697	37	16	no	no	ADV
dpc-1697	37	17	longer	long	ADV
dpc-1697	37	18	visible	visible	ADJ
dpc-1697	37	19	,	,	PUNCT
dpc-1697	37	20	and	and	CCONJ
dpc-1697	37	21	some	some	DET
dpc-1697	37	22	white	white	ADJ
dpc-1697	37	23	shiny	shiny	ADJ
dpc-1697	37	24	lines	line	NOUN
dpc-1697	37	25	can	can	AUX
dpc-1697	37	26	be	be	AUX
dpc-1697	37	27	identified	identify	VERB
dpc-1697	37	28	(	(	PUNCT
dpc-1697	37	29	black	black	ADJ
dpc-1697	37	30	arrows	arrow	NOUN
dpc-1697	37	31	)	)	PUNCT
dpc-1697	37	32	.	.	PUNCT
dpc-1697	38	1	(	(	PUNCT
dpc-1697	38	2	d	d	X
dpc-1697	38	3	)	)	PUNCT
dpc-1697	38	4	week	week	NOUN
dpc-1697	38	5	8	8	NUM
dpc-1697	38	6	:	:	PUNCT
dpc-1697	38	7	almost	almost	ADV
dpc-1697	38	8	no	no	PRON
dpc-1697	38	9	white	white	ADJ
dpc-1697	38	10	lines	line	NOUN
dpc-1697	38	11	and	and	CCONJ
dpc-1697	38	12	vessels	vessel	NOUN
dpc-1697	38	13	remain	remain	VERB
dpc-1697	38	14	.	.	PUNCT
dpc-1697	39	1	research	research	NOUN
dpc-1697	39	2	letter	letter	NOUN
dpc-1697	39	3	|	|	ADV
dpc-1697	39	4	dermatol	dermatol	ADJ
dpc-1697	39	5	pract	pract	NOUN
dpc-1697	39	6	concept	concept	NOUN
dpc-1697	39	7	.	.	PUNCT
dpc-1697	40	1	2022;12(1):e2022019	2022;12(1):e2022019	NUM
dpc-1697	40	2	3	3	NUM
dpc-1697	40	3	conclusions	conclusion	NOUN
dpc-1697	40	4	the	the	DET
dpc-1697	40	5	presence	presence	NOUN
dpc-1697	40	6	of	of	ADP
dpc-1697	40	7	multiple	multiple	ADJ
dpc-1697	40	8	bccs	bccs	NOUN
dpc-1697	40	9	is	be	AUX
dpc-1697	40	10	a	a	DET
dpc-1697	40	11	hallmark	hallmark	ADJ
dpc-1697	40	12	finding	finding	NOUN
dpc-1697	40	13	in	in	ADP
dpc-1697	40	14	gs	gs	NOUN
dpc-1697	41	1	[	[	X
dpc-1697	41	2	1	1	NUM
dpc-1697	41	3	]	]	PUNCT
dpc-1697	41	4	.	.	PUNCT
dpc-1697	42	1	bcc	bcc	PROPN
dpc-1697	42	2	accounts	account	VERB
dpc-1697	42	3	for	for	ADP
dpc-1697	42	4	90	90	NUM
dpc-1697	42	5	%	%	NOUN
dpc-1697	42	6	of	of	ADP
dpc-1697	42	7	malignant	malignant	ADJ
dpc-1697	42	8	periocular	periocular	ADJ
dpc-1697	42	9	tumors	tumor	NOUN
dpc-1697	42	10	and	and	CCONJ
dpc-1697	42	11	represents	represent	VERB
dpc-1697	42	12	4.4%-18.0	4.4%-18.0	NUM
dpc-1697	42	13	%	%	NOUN
dpc-1697	42	14	of	of	ADP
dpc-1697	42	15	all	all	DET
dpc-1697	42	16	bccs	bccs	NOUN
dpc-1697	43	1	[	[	X
dpc-1697	43	2	1	1	NUM
dpc-1697	43	3	]	]	PUNCT
dpc-1697	43	4	.	.	PUNCT
dpc-1697	44	1	most	most	ADJ
dpc-1697	44	2	periocular	periocular	ADJ
dpc-1697	44	3	bccs	bccs	NOUN
dpc-1697	44	4	are	be	AUX
dpc-1697	44	5	curable	curable	ADJ
dpc-1697	44	6	with	with	ADP
dpc-1697	44	7	surgery	surgery	NOUN
dpc-1697	44	8	;	;	PUNCT
dpc-1697	44	9	however	however	ADV
dpc-1697	44	10	,	,	PUNCT
dpc-1697	44	11	in	in	ADP
dpc-1697	44	12	patients	patient	NOUN
dpc-1697	44	13	with	with	ADP
dpc-1697	44	14	more	more	ADV
dpc-1697	44	15	extensive	extensive	ADJ
dpc-1697	44	16	involvement	involvement	NOUN
dpc-1697	44	17	,	,	PUNCT
dpc-1697	44	18	a	a	DET
dpc-1697	44	19	surgical	surgical	ADJ
dpc-1697	44	20	resection	resection	NOUN
dpc-1697	44	21	with	with	ADP
dpc-1697	44	22	curative	curative	ADJ
dpc-1697	44	23	intent	intent	NOUN
dpc-1697	44	24	may	may	AUX
dpc-1697	44	25	lead	lead	VERB
dpc-1697	44	26	to	to	ADP
dpc-1697	44	27	substantial	substantial	ADJ
dpc-1697	44	28	morbidity	morbidity	NOUN
dpc-1697	44	29	or	or	CCONJ
dpc-1697	44	30	deformity	deformity	NOUN
dpc-1697	44	31	because	because	SCONJ
dpc-1697	44	32	of	of	ADP
dpc-1697	44	33	the	the	DET
dpc-1697	44	34	need	need	NOUN
dpc-1697	44	35	to	to	PART
dpc-1697	44	36	remove	remove	VERB
dpc-1697	44	37	periocular	periocular	ADJ
dpc-1697	44	38	or	or	CCONJ
dpc-1697	44	39	orbital	orbital	ADJ
dpc-1697	44	40	tissues	tissue	NOUN
dpc-1697	44	41	that	that	PRON
dpc-1697	44	42	results	result	VERB
dpc-1697	44	43	in	in	ADP
dpc-1697	44	44	reduced	reduce	VERB
dpc-1697	44	45	functionality	functionality	NOUN
dpc-1697	44	46	and	and	CCONJ
dpc-1697	44	47	quality	quality	NOUN
dpc-1697	44	48	of	of	ADP
dpc-1697	44	49	life	life	NOUN
dpc-1697	44	50	[	[	X
dpc-1697	44	51	1	1	NUM
dpc-1697	44	52	]	]	PUNCT
dpc-1697	44	53	.	.	PUNCT
dpc-1697	45	1	other	other	ADJ
dpc-1697	45	2	therapeutic	therapeutic	ADJ
dpc-1697	45	3	modalities	modality	NOUN
dpc-1697	45	4	such	such	ADJ
dpc-1697	45	5	as	as	ADP
dpc-1697	45	6	photodynamic	photodynamic	ADJ
dpc-1697	45	7	therapy	therapy	NOUN
dpc-1697	45	8	and	and	CCONJ
dpc-1697	45	9	topical	topical	ADJ
dpc-1697	45	10	medications	medication	NOUN
dpc-1697	45	11	have	have	AUX
dpc-1697	45	12	been	be	AUX
dpc-1697	45	13	used	use	VERB
dpc-1697	45	14	as	as	ADP
dpc-1697	45	15	treatments	treatment	NOUN
dpc-1697	45	16	for	for	ADP
dpc-1697	45	17	small	small	ADJ
dpc-1697	45	18	or	or	CCONJ
dpc-1697	45	19	superficial	superficial	ADJ
dpc-1697	45	20	bccs	bccs	NOUN
dpc-1697	45	21	.	.	PUNCT
dpc-1697	46	1	radiotherapy	radiotherapy	NOUN
dpc-1697	46	2	should	should	AUX
dpc-1697	46	3	be	be	AUX
dpc-1697	46	4	avoided	avoid	VERB
dpc-1697	46	5	in	in	ADP
dpc-1697	46	6	gs	gs	NOUN
dpc-1697	47	1	[	[	X
dpc-1697	47	2	1	1	NUM
dpc-1697	47	3	]	]	PUNCT
dpc-1697	47	4	.	.	PUNCT
dpc-1697	48	1	vismodegib	vismodegib	PROPN
dpc-1697	48	2	is	be	AUX
dpc-1697	48	3	a	a	DET
dpc-1697	48	4	first	first	ADJ
dpc-1697	48	5	-	-	PUNCT
dpc-1697	48	6	in	in	ADP
dpc-1697	48	7	-	-	PUNCT
dpc-1697	48	8	class	class	NOUN
dpc-1697	48	9	inhibitor	inhibitor	NOUN
dpc-1697	48	10	of	of	ADP
dpc-1697	48	11	the	the	DET
dpc-1697	48	12	hps	hps	NOUN
dpc-1697	48	13	,	,	PUNCT
dpc-1697	48	14	and	and	CCONJ
dpc-1697	48	15	it	it	PRON
dpc-1697	48	16	reduces	reduce	VERB
dpc-1697	48	17	bcc	bcc	PROPN
dpc-1697	48	18	tumor	tumor	NOUN
dpc-1697	48	19	burden	burden	NOUN
dpc-1697	48	20	and	and	CCONJ
dpc-1697	48	21	blocks	block	VERB
dpc-1697	48	22	the	the	DET
dpc-1697	48	23	growth	growth	NOUN
dpc-1697	48	24	of	of	ADP
dpc-1697	48	25	new	new	ADJ
dpc-1697	48	26	bccs	bccs	NOUN
dpc-1697	48	27	in	in	ADP
dpc-1697	48	28	patients	patient	NOUN
dpc-1697	48	29	with	with	ADP
dpc-1697	48	30	gs	gs	PROPN
dpc-1697	49	1	[	[	X
dpc-1697	49	2	1	1	NUM
dpc-1697	49	3	]	]	PUNCT
dpc-1697	49	4	.	.	PUNCT
dpc-1697	50	1	vismodegib	vismodegib	PROPN
dpc-1697	50	2	has	have	AUX
dpc-1697	50	3	shown	show	VERB
dpc-1697	50	4	superior	superior	ADJ
dpc-1697	50	5	outcomes	outcome	NOUN
dpc-1697	50	6	compared	compare	VERB
dpc-1697	50	7	to	to	ADP
dpc-1697	50	8	other	other	ADJ
dpc-1697	50	9	therapies	therapy	NOUN
dpc-1697	50	10	;	;	PUNCT
dpc-1697	50	11	however	however	ADV
dpc-1697	50	12	,	,	PUNCT
dpc-1697	50	13	complete	complete	ADJ
dpc-1697	50	14	histologic	histologic	ADJ
dpc-1697	50	15	clearance	clearance	NOUN
dpc-1697	50	16	is	be	AUX
dpc-1697	50	17	not	not	PART
dpc-1697	50	18	always	always	ADV
dpc-1697	50	19	achieved	achieve	VERB
dpc-1697	50	20	,	,	PUNCT
dpc-1697	50	21	and	and	CCONJ
dpc-1697	50	22	risk	risk	NOUN
dpc-1697	50	23	of	of	ADP
dpc-1697	50	24	progression	progression	NOUN
dpc-1697	50	25	or	or	CCONJ
dpc-1697	50	26	recurrence	recurrence	NOUN
dpc-1697	50	27	has	have	AUX
dpc-1697	50	28	been	be	AUX
dpc-1697	50	29	described	describe	VERB
dpc-1697	50	30	after	after	ADP
dpc-1697	50	31	treatment	treatment	NOUN
dpc-1697	50	32	cessation	cessation	NOUN
dpc-1697	51	1	[	[	X
dpc-1697	51	2	1	1	NUM
dpc-1697	51	3	]	]	PUNCT
dpc-1697	51	4	.	.	PUNCT
dpc-1697	52	1	sdd	sdd	NOUN
dpc-1697	52	2	is	be	AUX
dpc-1697	52	3	used	use	VERB
dpc-1697	52	4	for	for	ADP
dpc-1697	52	5	monitoring	monitor	VERB
dpc-1697	52	6	bccs	bccs	NOUN
dpc-1697	52	7	response	response	NOUN
dpc-1697	52	8	to	to	ADP
dpc-1697	52	9	topical	topical	ADJ
dpc-1697	52	10	chemotherapy	chemotherapy	NOUN
dpc-1697	53	1	[	[	X
dpc-1697	53	2	2	2	NUM
dpc-1697	53	3	]	]	PUNCT
dpc-1697	53	4	.	.	PUNCT
dpc-1697	54	1	the	the	DET
dpc-1697	54	2	presence	presence	NOUN
dpc-1697	54	3	or	or	CCONJ
dpc-1697	54	4	disappearance	disappearance	NOUN
dpc-1697	54	5	of	of	ADP
dpc-1697	54	6	bcc	bcc	PROPN
dpc-1697	54	7	dermoscopic	dermoscopic	NOUN
dpc-1697	54	8	criteria	criterion	NOUN
dpc-1697	54	9	correlates	correlate	VERB
dpc-1697	54	10	with	with	ADP
dpc-1697	54	11	tumor	tumor	NOUN
dpc-1697	54	12	persistence	persistence	NOUN
dpc-1697	54	13	or	or	CCONJ
dpc-1697	54	14	histopathologic	histopathologic	ADJ
dpc-1697	54	15	clearance	clearance	NOUN
dpc-1697	54	16	respectively	respectively	ADV
dpc-1697	54	17	[	[	X
dpc-1697	54	18	2	2	NUM
dpc-1697	54	19	]	]	PUNCT
dpc-1697	54	20	.	.	PUNCT
dpc-1697	55	1	blue	blue	ADJ
dpc-1697	55	2	-	-	PUNCT
dpc-1697	55	3	gray	gray	ADJ
dpc-1697	55	4	globules	globule	NOUN
dpc-1697	55	5	and	and	CCONJ
dpc-1697	55	6	ovoid	ovoid	ADJ
dpc-1697	55	7	nests	nest	NOUN
dpc-1697	55	8	can	can	AUX
dpc-1697	55	9	be	be	AUX
dpc-1697	55	10	detected	detect	VERB
dpc-1697	55	11	for	for	ADP
dpc-1697	55	12	a	a	DET
dpc-1697	55	13	longer	long	ADJ
dpc-1697	55	14	period	period	NOUN
dpc-1697	55	15	of	of	ADP
dpc-1697	55	16	time	time	NOUN
dpc-1697	55	17	,	,	PUNCT
dpc-1697	55	18	whereas	whereas	SCONJ
dpc-1697	55	19	other	other	ADJ
dpc-1697	55	20	typical	typical	ADJ
dpc-1697	55	21	structures	structure	NOUN
dpc-1697	55	22	decrease	decrease	VERB
dpc-1697	55	23	in	in	ADP
dpc-1697	55	24	size	size	NOUN
dpc-1697	55	25	and	and	CCONJ
dpc-1697	55	26	number	number	NOUN
dpc-1697	55	27	after	after	ADP
dpc-1697	55	28	chemotherapy	chemotherapy	NOUN
dpc-1697	55	29	initiation	initiation	NOUN
dpc-1697	55	30	[	[	X
dpc-1697	55	31	2	2	NUM
dpc-1697	55	32	]	]	PUNCT
dpc-1697	55	33	.	.	PUNCT
dpc-1697	56	1	there	there	PRON
dpc-1697	56	2	is	be	VERB
dpc-1697	56	3	lack	lack	NOUN
dpc-1697	56	4	of	of	ADP
dpc-1697	56	5	evidence	evidence	NOUN
dpc-1697	56	6	about	about	ADP
dpc-1697	56	7	sdd	sdd	NOUN
dpc-1697	56	8	of	of	ADP
dpc-1697	56	9	bccs	bccs	NOUN
dpc-1697	56	10	in	in	ADP
dpc-1697	56	11	patients	patient	NOUN
dpc-1697	56	12	with	with	ADP
dpc-1697	56	13	gs	gs	PROPN
dpc-1697	56	14	treated	treat	VERB
dpc-1697	56	15	with	with	ADP
dpc-1697	56	16	vismodegib	vismodegib	NOUN
dpc-1697	56	17	.	.	PUNCT
dpc-1697	57	1	sdd	sdd	NOUN
dpc-1697	57	2	may	may	AUX
dpc-1697	57	3	help	help	VERB
dpc-1697	57	4	in	in	ADP
dpc-1697	57	5	detecting	detect	VERB
dpc-1697	57	6	subtle	subtle	ADJ
dpc-1697	57	7	changes	change	NOUN
dpc-1697	57	8	and	and	CCONJ
dpc-1697	57	9	in	in	ADP
dpc-1697	57	10	facilitating	facilitate	VERB
dpc-1697	57	11	the	the	DET
dpc-1697	57	12	diagnosis	diagnosis	NOUN
dpc-1697	57	13	of	of	ADP
dpc-1697	57	14	recurrence	recurrence	NOUN
dpc-1697	57	15	or	or	CCONJ
dpc-1697	57	16	progression	progression	NOUN
dpc-1697	57	17	of	of	ADP
dpc-1697	57	18	bccs	bccs	NOUN
dpc-1697	57	19	in	in	ADP
dpc-1697	57	20	patients	patient	NOUN
dpc-1697	57	21	treated	treat	VERB
dpc-1697	57	22	with	with	ADP
dpc-1697	57	23	vismodegib	vismodegib	NOUN
dpc-1697	57	24	or	or	CCONJ
dpc-1697	57	25	alternative	alternative	ADJ
dpc-1697	57	26	treatments	treatment	NOUN
dpc-1697	57	27	other	other	ADJ
dpc-1697	57	28	than	than	ADP
dpc-1697	57	29	surgery	surgery	NOUN
dpc-1697	57	30	.	.	PUNCT
dpc-1697	58	1	references	reference	NOUN
dpc-1697	58	2	1	1	NUM
dpc-1697	58	3	.	.	PUNCT
dpc-1697	59	1	herms	herm	NOUN
dpc-1697	59	2	f	f	PROPN
dpc-1697	59	3	,	,	PUNCT
dpc-1697	59	4	lambert	lambert	PROPN
dpc-1697	59	5	j	j	PROPN
dpc-1697	59	6	,	,	PUNCT
dpc-1697	59	7	grob	grob	PROPN
dpc-1697	59	8	jj	jj	PROPN
dpc-1697	59	9	,	,	PUNCT
dpc-1697	59	10	et	et	PROPN
dpc-1697	59	11	al	al	PROPN
dpc-1697	59	12	.	.	PUNCT
dpc-1697	60	1	follow	follow	PROPN
dpc-1697	60	2	-	-	PUNCT
dpc-1697	60	3	up	up	NOUN
dpc-1697	60	4	of	of	ADP
dpc-1697	60	5	patients	patient	NOUN
dpc-1697	60	6	with	with	ADP
dpc-1697	60	7	complete	complete	ADJ
dpc-1697	60	8	remission	remission	NOUN
dpc-1697	60	9	of	of	ADP
dpc-1697	60	10	locally	locally	ADV
dpc-1697	60	11	advanced	advance	VERB
dpc-1697	60	12	basal	basal	NOUN
dpc-1697	60	13	cell	cell	NOUN
dpc-1697	60	14	carcinoma	carcinoma	NOUN
dpc-1697	60	15	after	after	ADP
dpc-1697	60	16	vismodegib	vismodegib	PROPN
dpc-1697	60	17	discontinuation	discontinuation	NOUN
dpc-1697	60	18	:	:	PUNCT
dpc-1697	60	19	a	a	DET
dpc-1697	60	20	multicenter	multicenter	ADJ
dpc-1697	60	21	french	french	ADJ
dpc-1697	60	22	study	study	NOUN
dpc-1697	60	23	of	of	ADP
dpc-1697	60	24	116	116	NUM
dpc-1697	60	25	patients	patient	NOUN
dpc-1697	60	26	.	.	PUNCT
dpc-1697	61	1	j	j	PROPN
dpc-1697	61	2	clin	clin	PROPN
dpc-1697	61	3	oncol	oncol	PROPN
dpc-1697	61	4	.	.	PUNCT
dpc-1697	62	1	2019;37(34):3275	2019;37(34):3275	NUM
dpc-1697	62	2	-	-	SYM
dpc-1697	62	3	3282	3282	NUM
dpc-1697	62	4	.	.	PUNCT
dpc-1697	63	1	doi	doi	NOUN
dpc-1697	63	2	:	:	PUNCT
dpc-1697	63	3	10.1200	10.1200	NUM
dpc-1697	63	4	/	/	SYM
dpc-1697	63	5	jco.18.00794	jco.18.00794	PROPN
dpc-1697	63	6	.	.	PUNCT
dpc-1697	64	1	pmid	pmid	NOUN
dpc-1697	64	2	:	:	PUNCT
dpc-1697	64	3	31609670	31609670	NUM
dpc-1697	64	4	.	.	PUNCT
dpc-1697	65	1	grajdeanu	grajdeanu	PROPN
dpc-1697	65	2	ia	ia	PROPN
dpc-1697	65	3	,	,	PUNCT
dpc-1697	65	4	vata	vata	PROPN
dpc-1697	65	5	d	d	PROPN
dpc-1697	65	6	,	,	PUNCT
dpc-1697	65	7	statescu	statescu	PROPN
dpc-1697	65	8	l	l	PROPN
dpc-1697	65	9	,	,	PUNCT
dpc-1697	65	10	et	et	PROPN
dpc-1697	65	11	al	al	PROPN
dpc-1697	65	12	.	.	PUNCT
dpc-1697	65	13	use	use	NOUN
dpc-1697	65	14	of	of	ADP
dpc-1697	65	15	imaging	imaging	NOUN
dpc-1697	65	16	techniques	technique	NOUN
dpc-1697	65	17	for	for	ADP
dpc-1697	65	18	melanocytic	melanocytic	ADJ
dpc-1697	65	19	naevi	naevi	NOUN
dpc-1697	65	20	and	and	CCONJ
dpc-1697	65	21	basal	basal	NOUN
dpc-1697	65	22	cell	cell	NOUN
dpc-1697	65	23	carcinoma	carcinoma	NOUN
dpc-1697	65	24	in	in	ADP
dpc-1697	65	25	integrative	integrative	ADJ
dpc-1697	65	26	analysis	analysis	NOUN
dpc-1697	65	27	(	(	PUNCT
dpc-1697	65	28	review	review	NOUN
dpc-1697	65	29	)	)	PUNCT
dpc-1697	65	30	.	.	PUNCT
dpc-1697	66	1	exp	exp	NOUN
dpc-1697	66	2	ther	ther	PROPN
dpc-1697	66	3	med	med	PROPN
dpc-1697	66	4	.	.	PUNCT
dpc-1697	67	1	2020;20(1):78	2020;20(1):78	PROPN
dpc-1697	67	2	-	-	SYM
dpc-1697	67	3	86	86	NUM
dpc-1697	67	4	.	.	PUNCT
dpc-1697	68	1	doi	doi	NOUN
dpc-1697	68	2	:	:	PUNCT
dpc-1697	68	3	10.3892/	10.3892/	NUM
dpc-1697	68	4	etm.2020.8620	etm.2020.8620	X
dpc-1697	68	5	.	.	PUNCT
dpc-1697	69	1	pmid	pmid	NOUN
dpc-1697	69	2	:	:	PUNCT
dpc-1697	69	3	32508998	32508998	NUM
dpc-1697	69	4	;	;	PUNCT
dpc-1697	69	5	pmcid	pmcid	ADJ
dpc-1697	69	6	:	:	PUNCT
dpc-1697	69	7	pmc7271701	pmc7271701	X
dpc-1697	69	8	.	.	PUNCT